Results 91 to 100 of about 848 (155)

Pivotal Trials in Heart Failure in 2024-Putting Evidence into Clinical Practice! [PDF]

Int J Angiol
Thandi P, Pradhan A, Behera SK.
europepmc   +1 more source

EMPACT-ing prognosis: Tailoring SGLT2i therapy with GDF-15

International Journal of Cardiology
Monzo, Luca, Girerd, Nicolas
openaire   +2 more sources

The challenges in improving myocardial infarction outcomes and the year 2024 in a nutshell. [PDF]

Future Cardiol
Zaman MA.
europepmc   +1 more source

Empagliflozin in Heart Failure and Previous Coronary Revascularization: Insights From EMPEROR-Pooled. [PDF]

JACC Adv
Dhingra NK, Butler J, Anker SD, Ferreira JP, Filippatos G, Pfarr E, Gasior T, Nordaby M, Brueckmann M, Pocock SJ, Zannad F, Packer M, Verma S, EMPEROR-Pooled Trial Committees and Investigators.   +13 more
europepmc   +1 more source

Early initiation of SGLT2 inhibitors in acute myocardial infarction and cardiovascular outcomes, an updated systematic review and meta-analysis. [PDF]

BMC Cardiovasc Disord
Semirani-Nezhad D, Soleimani H, Taebi M, Roozbehi K, Jahangiri S, Sattartabar B, Takaloo F, Parastooei B, Asfa E, Salabat D, Alishahi MM, Mosayebi F, Jenab Y, Gupta R, Kuno T, Aronow W, Hosseini K.   +16 more
europepmc   +1 more source

Head-to-Head in Heart Failure: Comparative Insights on Empagliflozin and Dapagliflozin. [PDF]

Biomedicines
Cozma D, Văcărescu C, Stoicescu C.
europepmc   +1 more source

Empagliflozin and Colchicine in Patients With Reduced Left Ventricular Ejection Fraction Following ST-Elevation Myocardial Infarction: A Systematic Review. [PDF]

Cureus
Asante Baadu F, Arif MA, Riaz Z, Argariya M, Rani K, Iqbal M.   +5 more
europepmc   +1 more source

Accelerating histopathology workflows with generative AI-based virtually multiplexed tumour profiling. [PDF]

Nat Mach Intell
Pati P, Karkampouna S, Bonollo F, Compérat E, Radić M, Spahn M, Martinelli A, Wartenberg M, Kruithof-de Julio M, Rapsomaniki M.   +9 more
europepmc   +1 more source

Multiplexed tumor profiling with generative AI accelerates histopathology workflows and improves clinical predictions

, 2023
Rapsomaniki MA, Pati P, Karkampouna S, Bonollo F, Comperat E, Radic M, Spahn M, Martinelli A, Wartenberg M, Julio MK.   +9 more
europepmc   +2 more sources

Sodium-Glucose Cotransporter-2 Inhibitors in Anthracycline-Treated Cancer Patients: A Narrative Review of Emerging Cardioprotective Evidence. [PDF]

Cureus
Nabhan E, Vana AP, Khouri R, Naoum Nehme E, Poulos N.   +4 more
europepmc   +1 more source